[1]
Absetz, P. et al. 2009. Type 2 Diabetes Prevention in the Real World: Three-year results of the GOAL Lifestyle Implementation Trial. Diabetes Care. 32, 8 (Aug. 2009), 1418–1420. DOI:https://doi.org/10.2337/dc09-0039.
[2]
Ackermann, R.T. et al. 2008. Translating the Diabetes Prevention Program into the Community. American Journal of Preventive Medicine. 35, 4 (Oct. 2008), 357–363. DOI:https://doi.org/10.1016/j.amepre.2008.06.035.
[3]
Carter, P. et al. 2012. Dietary Recommendations for the Prevention of Type 2 diabetes: What Are They Based on? Journal of Nutrition and Metabolism. 2012, (2012), 1–6. DOI:https://doi.org/10.1155/2012/847202.
[4]
Chiasson, J.-L. et al. 2002. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. The Lancet. 359, 9323 (Jun. 2002), 2072–2077. DOI:https://doi.org/10.1016/S0140-6736(02)08905-5.
[5]
Church, T.S. et al. 2004. Exercise Capacity and Body Composition as Predictors of Mortality Among Men With Diabetes. Diabetes Care. 27, 1 (Jan. 2004), 83–88. DOI:https://doi.org/10.2337/diacare.27.1.83.
[6]
Colberg, S.R. et al. 2010. Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care. 33, 12 (Dec. 2010), 2692–2696. DOI:https://doi.org/10.2337/dc10-1548.
[7]
Cordain, L. et al. 1998. Physical Activity, Energy Expenditure and Fitness: An Evolutionary Perspective. International Journal of Sports Medicine. 19, 05 (Jul. 1998), 328–335. DOI:https://doi.org/10.1055/s-2007-971926.
[8]
DeFronzo, R.A. et al. 2011. Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance. New England Journal of Medicine. 364, 12 (Mar. 2011), 1104–1115. DOI:https://doi.org/10.1056/NEJMoa1010949.
[9]
Dyson, P.A. et al. 2011. Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabetic Medicine. 28, 11 (Nov. 2011), 1282–1288. DOI:https://doi.org/10.1111/j.1464-5491.2011.03371.x.
[10]
Frank W. Booth 2000. Waging war on modern chronic diseases: primary prevention through exercise biology. Journal of Applied Physiology. 88, 2 (2000), 774–787.
[11]
Gillies, C.L. et al. 2007. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 334, 7588 (Jan. 2007), 299–299. DOI:https://doi.org/10.1136/bmj.39063.689375.55.
[12]
Gray, L.J. et al. 2011. Defining Obesity Cut-Off Points for Migrant South Asians. PLoS ONE. 6, 10 (Oct. 2011). DOI:https://doi.org/10.1371/journal.pone.0026464.
[13]
Greaves, C.J. et al. 2011. Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions. BMC Public Health. 11, 1 (2011). DOI:https://doi.org/10.1186/1471-2458-11-119.
[14]
Hamman, R.F. et al. 2006. Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes. Diabetes Care. 29, 9 (Sep. 2006), 2102–2107. DOI:https://doi.org/10.2337/dc06-0560.
[15]
Laaksonen, D.E. et al. 2005. Physical Activity in the Prevention of Type 2 Diabetes: The Finnish Diabetes Prevention Study. Diabetes. 54, 1 (Jan. 2005), 158–165. DOI:https://doi.org/10.2337/diabetes.54.1.158.
[16]
Lindstrom, J. et al. 2003. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 26, 12 (Dec. 2003), 3230–3236. DOI:https://doi.org/10.2337/diacare.26.12.3230.
[17]
Norris, S.L. et al. 1996. Long-term non-pharmacological weight loss interventions for adults with prediabetes. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd.
[18]
Pan, X.-R. et al. 1997. Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care. 20, 4 (Apr. 1997), 537–544. DOI:https://doi.org/10.2337/diacare.20.4.537.
[19]
Ramachandran, A. et al. 2006. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 49, 2 (Feb. 2006), 289–297. DOI:https://doi.org/10.1007/s00125-005-0097-z.
[20]
Schwarz, P.E. et al. 2012. Nonpharmacological interventions for the prevention of type 2 diabetes mellitus. Nature Reviews Endocrinology. (Jan. 2012). DOI:https://doi.org/10.1038/nrendo.2011.232.
[21]
Schwarz, P.E.H. et al. 2007. Development and Implementation of A European Guideline and Training Standards for Diabetes Prevention-The IMAGE project. Journal of Public Health. 15, 5 (Sep. 2007), 353–360. DOI:https://doi.org/10.1007/s10389-007-0145-x.
[22]
Schwarz, P.E.H. 2011. Public Health Implications: Translation into Diabetes Prevention Initiatives—Four-Level Public Health Concept. Medical Clinics of North America. 95, 2 (Mar. 2011), 397–407. DOI:https://doi.org/10.1016/j.mcna.2010.11.008.
[23]
Steven N Blair 2009. Physical inactivity: the biggest public health problem of the 21st century. British Journal of Sports Medicine. 43, (Jan. 2009), 1–2.
[24]
TELFORD, RICHARD D. Low Physical Activity and Obesity: Causes of Chronic Disease or Simply Predictors? Medicine & Science in Sports & Exercise. 39, 8.
[25]
The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts: http://link.springer.com/article/10.1007/s10654-009-9405-0/fulltext.html.
[26]
Tuomilehto, J. et al. 2001. Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. New England Journal of Medicine. 344, 18 (May 2001), 1343–1350. DOI:https://doi.org/10.1056/NEJM200105033441801.
[27]
Umpierre, D. 2011. Physical Activity Advice Only or Structured Exercise Training and Association With HbA                              Levels in Type 2 Diabetes. JAMA. 305, 17 (May 2011). DOI:https://doi.org/10.1001/jama.2011.576.
[28]
Yates, T. et al. 2009. Effectiveness of a Pragmatic Education Program Designed to Promote Walking Activity in Individuals With Impaired Glucose Tolerance: A randomized controlled trial. Diabetes Care. 32, 8 (Aug. 2009), 1404–1410. DOI:https://doi.org/10.2337/dc09-0130.
[29]
Yates, T. et al. 2011. Stand up for your health: Is it time to rethink the physical activity paradigm? Diabetes Research and Clinical Practice. 93, 2 (Aug. 2011), 292–294. DOI:https://doi.org/10.1016/j.diabres.2011.03.023.
[30]
Yates, T. et al. 2009. The role of physical activity in the management of type 2 diabetes mellitus. Postgraduate Medical Journal. 85, 1001 (Mar. 2009), 129–133. DOI:https://doi.org/10.1136/pgmj.2008.067900.
[31]
2010. Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events. New England Journal of Medicine. 362, 16 (Apr. 2010), 1463–1476. DOI:https://doi.org/10.1056/NEJMoa1001122.
[32]
2010. Effect of Valsartan on the Incidence of Diabetes. New England Journal of Medicine. 363, 8 (Aug. 2010), 792–793. DOI:https://doi.org/10.1056/NEJMc1005899.
[33]
2008. Nutrition Recommendations and Interventions for Diabetes: A position statement of the American Diabetes Association. Diabetes Care. 31, Supplement 1 (Jan. 2008), S61–S78. DOI:https://doi.org/10.2337/dc08-S061.
[34]
2015. Public Health England - Diabetes prevention programmes: evidence review. Public Health England.
[35]
2002. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine. 346, 6 (Feb. 2002), 393–403. DOI:https://doi.org/10.1056/NEJMoa012512.
[36]
2007. Screening for type 2 diabetes: literature review and economic modelling. Clinical Governance: An International Journal. 12, 4 (Oct. 2007). DOI:https://doi.org/10.1108/cgij.2007.24812dae.003.